
1. cell rep. 2020 sep 22;32(12):108170. doi: 10.1016/j.celrep.2020.108170.

bisphosphoglycerate mutase deficiency protects cerebral malaria and
severe malaria-induced anemia.

xu g(1), van bruggen r(2), gualtieri co(2), moradin n(3), fois a(4), vallerand
d(5), de sa tavares russo m(6), bassenden a(7), lu w(8), tam m(9), lesage s(4),
girouard h(5), avizonis dz(6), deblois g(10), prchal jt(11), stevenson m(9),
berghuis a(7), muir t(12), rabinowitz j(12), vidal sm(13), fodil n(14), gros
p(15).

author information: 
(1)department human genetics, mcgill university, montreal, qc h3a 0c7, canada;
mcgill university research centre complex traits, mcgill university, montreal,
qc h3g 0b1, canada.
(2)mcgill university research centre complex traits, mcgill university,
montreal, qc h3g 0b1, canada; department biochemistry, mcgill university,
montreal, qc h3a 1a3, canada.
(3)mcgill university research centre complex traits, mcgill university,
montreal, qc h3g 0b1, canada.
(4)immunology-oncology unit, maisonneuve-rosemont hospital research center,
montréal, qc h1t 2m4, canada; département de microbiologie, infectiologie et
immunologie, université de montréal, montréal, qc h3t 1j4, canada.
(5)université de montréal, département de pharmacologie et physiologie, pav
roger-gaudry, 2900 édouard-montpetit, montréal, qc h3t 1j4, canada.
(6)rosalind morris goodman cancer research centre, 1160 pin avenue west,
montréal, qc h3a 1a3, canada.
(7)department biochemistry, mcgill university, montreal, qc h3a 1a3, canada.
(8)lewis sigler institute integrative genomics, princeton university,
princeton, nj 08544, usa.
(9)department microbiology immunology, mcgill university, montréal, qc h3a
2b4, canada.
(10)institute research immunology cancer, université de montréal,
montréal, qc h3t 1j4, canada; faculté de pharmacie, université de montréal,
montréal, qc h3c 3j7, canada.
(11)division hematology, school medicine, university utah, salt lake
city, ut 84132, usa.
(12)lewis sigler institute integrative genomics, princeton university,
princeton, nj 08544, usa; department chemistry, princeton university,
princeton, nj 08544, usa.
(13)department human genetics, mcgill university, montreal, qc h3a 0c7,
canada; mcgill university research centre complex traits, mcgill university,
montreal, qc h3g 0b1, canada; department microbiology immunology, mcgill
university, montréal, qc h3a 2b4, canada.
(14)mcgill university research centre complex traits, mcgill university,
montreal, qc h3g 0b1, canada; centre cermo-fc pavillon des sciences biologiques, 
141 avenue du président kennedy, montréal, qc h2x 3y7, canada. electronic
address: nassima.fodil@mcgill.ca.
(15)department human genetics, mcgill university, montreal, qc h3a 0c7,
canada; mcgill university research centre complex traits, mcgill university,
montreal, qc h3g 0b1, canada; department biochemistry, mcgill university,
montreal, qc h3a 1a3, canada. electronic address: philippe.gros@mcgill.ca.

the replication cycle pathogenesis plasmodium malarial parasite
involves rapid expansion red blood cells (rbcs), variants certain
rbc-specific proteins protect malaria humans. rbcs,
bisphosphoglycerate mutase (bpgm) acts key allosteric regulator of
hemoglobin/oxyhemoglobin. demonstrate loss-of-function mutation in
the murine bpgm (bpgml166p) gene confers protection both
plasmodium-induced cerebral malaria blood-stage malaria. malaria
protection seen bpgml166p mutant mice associated reduced blood
parasitemia levels, milder clinical symptoms, increased survival. the
protective effect bpgml166p involves dual mechanism enhances host's
stress erythroid response plasmodium-driven rbc loss simultaneously alters
the intracellular milieu rbcs, including increased oxyhemoglobin and
reduced energy metabolism, reducing plasmodium maturation, replication.
overall, study highlights importance bpgm regulator of
hemoglobin/oxyhemoglobin malaria pathogenesis suggests new potential
malaria therapeutic target.

copyright © 2020 author(s). published elsevier inc. rights reserved.

doi: 10.1016/j.celrep.2020.108170 
pmid: 32966787 

conflict interest statement: declaration interests authors declare no
competing interests.

